Table 2.
Linear regression of echocardiographic parameters on the Sokolow-Lyon index
| Crude betaa (95 % CI) | p | Adjusted betaa,b (95 % CI) | p | |
|---|---|---|---|---|
| LVMI (g/m2) | 4.19 (1.40–6.99) | 0.0033 | 7.02 (4.49–9.54) | <0.0001 |
| LVIDd (cm/m2) | 0.10 (0.08–0.12) | <0.0001 | 0.06 (0.04–0.08) | <0.0001 |
| PWTd (cm) | −0.01 (−0.02–0.00) | 0.1533 | 0.01 (0.00–0.02) | 0.1078 |
| SWTd (cm) | −0.01 (−0.02–0.00) | 0.1435 | 0.01 (0.00–0.02) | 0.0927 |
| Dichotomized outcome for impaired echocardiographic LVH parameters [13] (odds ratios) | ||||
| LVMI | 1.37 (0.67–2.79) | 0.3892 | 1.59 (0.74–3.42) | 0.233 |
| LVIDd | 1.93 (0.81–4.61) | 0.1379 | 1.24 (0.48–3.16) | 0.6572 |
| PWTd | 2 (0.48–8.29) | 0.341 | 2.62 (0.59–11.59) | 0.2041 |
| SWTd | 2.25 (0.54–9.32) | 0.2633 | 2.66 (0.6–11.81) | 0.1993 |
SLI Sokolow-Lyon index, LVMI left ventricular mass index, LVIDd left-ventricular internal diameter at end-diastole index, PWTd left-ventricular posterior wall thickness at end-diastole, SWTd septal wall thickness at end-diastole, 95 % CI 95 % confidence interval
aadjusted for sex, sport index, smoking status, NT-pro BNP, low density lipoprotein, arterial hypertension, waist-to-hip ratio, diabetes mellitus, regular intake of antiarrhythmic medication, beta blockers and digitalis glycosides
bBeta gives the increase of the respective echocardiographic parameter per mV increase of the SLI